Thirteen/Fourteen Flashcards

(37 cards)

1
Q

Why is ionized calcium important? What are calcium’s major storage sites? What are the three forms of calcium in circulation? What percent do they each make up? What is a normal range for serum total calcium? Explain which organs allow homeostasis of calcium to be maintained.

A
  1. Ionized calcium important for structural support, muscle contraction, clotting, impulse conduction in heart and nerves, intracellular signaling cascades, and exocrine and endocrine secretion events.
  2. Major storage sites: teeth and bone.
  3. Three forms in circulation: ionized (50%), protein-bound (40%), soluble complexes (10%).
  4. Normal range of serum total calcium: 8.5% -10.3 mg/dl.

Calcium homeostasis is maintained by transfer between blood and three major tissues: Bone, kidney, and intestine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the two types of bone mass? What are they like? Where are they located? What percent of mass and area of bone do they make up? What is the BMU? What are its parts?

A

Cortical: 80% of bone mass, highly

mineralized, appendicular skeleton (arms

and legs)

Trabecular: marrow-containing (spine, metaphyses), comprises 80% of bone surface area, major site of remodeling.

BMU: basic multicellular unit is responsible for bone remodeling.

Osteoclast, osteoblast, osteocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the formation, activation, action, and mechanism of action of the osteoclast.

A
  1. Role of the osteoclast: derived from precursor monocyte/macrophages. M-CSF (macrophage

colony stimulating factor) directs monocytes to preosteoclast phenotype. Presence of RANK

(receptor for activation of nuclear factor kappa b) which binds to RANKL (RANK receptor

ligand) drives differentiation to the activated state. This can be blocked by OPG
(oseoprotegerin) . Activation of c-Src

(a proto-oncogene product involved

in cell growth control) allows cell to

polarize, attach to the bone (via

integrins) and form a ruffled surface

adjacent to the bone. Proton pumps in

the ruffled membrane secrete H+ ions

which dissolve the hydroxyapatite

crystals in bone and enzymes released

from the osteoclast (cathepsin K and

matrix metalloproteinase 9) cleave the

structural proteins. After about 2

weeks the osteoclasts release from bone and undergo apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the formation, activation, action, and mechanism of action of the osteoblast.

A
  1. Role of osteoblast:

mesenchymal precursors

(of myocytes, adipocytes, fibroblasts or osteoblasts)

exposed to BMP (bone

morphogenic protein) and

Cbfa1(core-binding factor 1) differentiate into osteoblasts. Further exposure to Cbfa1 activates the osteoblasts.

Osteoblasts follow the furrow left behind by the osteoclasts and deposit osteoid (bone matrix

proteins, mainly type 1 collagen) and minerals forming hydroxyapatite crystals

[Ca10(PO4)6(OH)2]. Osteoblasts last about three months, some go into apoptosis, others transform into osteocytes (90% of cell mass of bone, connected via cytoplasmic processes in the bony cannuliculi).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the role of osteocytes?

A
  1. Role of osteocytes; thought to be mechanosensors. Increased strain favors bone formation, decreased strain favors bone resorption.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How much calcium is excreted in urine daily? What percent of filtered load is reabsorbed? What percent is reabsorbed in the various parts of the nephron and how?

A
  1. Average daily urinary excretion 100-200 mg.
  2. 80-90% of filtered load reabsorbed.

60-70% in proximal tubule (passive absorption driven by lumen-positive transepithelial potential difference, Ca++/H+ exchanger requires HCO3

no Ca++ transport in descending limb of Loop of Henle

20% in thick ascending limb of Loop of Henle (passive as well, lumen positive transepithelial gradient)

5-10% in distal tubule (where majority of active reabsorption occurs, transepithelial voltage gradient now lumen negative)

remainder in collecting ducts (passive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the mechanism of action of calcium transport in the distal tubule.

A
  1. Distal tubule mechanism: Luminal epithelial calcium channels (ECaC1 and ECaC2, a.k.a. TRPV5 and TRPV6) permit Ca++ entry down the potential gradient
    (inside cell negative relative to lumen). Inside cell Ca++ binds to calbindin-D28K and calbindin-D9K (protects against toxic levels and maintains the electrochemical
    gradient) which facilitate diffusion to the basolateral membrane, where the plasma membrane calcium
    ATPase (PMCA) pumps Ca++ out of cell. There is also a basolateral membrane Na+/Ca++ exchanger (stimulated by PTH). (Fig 14-4,

Kovacs and Ojeda, p. 386)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does renal filtration affect calcium handling? PTH? How Acidosis? How? Alkalosis? How? Excess dietary salt? How? Loop diuretics? How? Thiazides? How? Vitamin D? How?

A
  1. Factors affecting renal Ca++ handling:

Renal filtration: decreases result in decreased urinary Ca++. Increases result in increased Ca++ lost in urine.

PTH improves renal Ca++ reabsorption (see below)

Acidosis or increased dietary acid load impairs reabsorption (increased luminal H+ inhibits TRPV5 Ca++ channels in Distal Tubule)

Alkalosis increases reabsorption (need luminal HCO3 for Ca++/H+ exchange in proximal tubule)

Excess dietary salt decreases reabsorption (solvent drag).

Loop diuretics (e.g. furosemide) decrease reabsorption by decreasing transepithelial voltage gradient in thick ascending limb (inhibition of the Na+/Cl-triporter)

Thiazide diuretics and lithium enhance reabsorption. (Thiazide diuretics work by blocking distal nephron Na+/ Cl co-transporter lowering intracellular Cl-hyperpolarizing the cell. This hyperpolarization opens voltage sensitive
calcium channels [TRPV5] and calcium enters cell.)

Vitamin D (Calcitriol) increases calbindin expression (facilitates transcellular calcium movement).

PTH increases activity of basolateral Na+/Ca++ exchanger further hyperpolarizing the cell and opening TRPV5 channels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where does most absorption occur in the intestine? When does active absorption occur? How? When does passive absorption occur? What substances impair absorption? Enhance it?

A
  1. Rate of absorption greatest in duodenum, but

long transit time in jejunum means most

absorption there. Of the approximately 1000

mg ingested per day, 360 mg is absorbed (in

equilibrium states that is matched by urinary

and fecal loss of equal amounts of Ca++).

  1. Absorption is active (across the cell) most

important at low dietary intakes.

  1. Passive absorption (between cells) important

at high dietary intakes.

  1. Dietary fiber and phosphate impair absorption.
  2. Sugars can enhance absorption acutely (e.g. calcium gluconate oral solution).
  3. Absorption similar to distal tubule, but no calbindin-D28K only calbindin-D9K.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How are PTH levels physiologically controlled? What is the PTH receptor like? What are the 2 basic actions of PTH? What are 4 ways in which it accomplishes those? What are 3 regulators of PTH levels? What are their mechanisms?

A
  1. Physiologic control exerted not on secretion, but on production.
  2. PTH receptor is a G-protein couple receptor signaling through Gs (cAMP and PKA) and through Gq (PLC, PKC and intracellular Ca++ mobilization).
  3. PTH actions (raise serum Ca++, lower serum PO4)
     Stimulates osteoclast reabsorption of bone
     Increase renal Ca++ reabsorption
     Augments production of 1,25-dihydroxyvitamin D in kidney
     Augments renal phosphate excretion
  4. PTH production
     Decreased ionized serum Ca++ results in increased PTH production/secretion
     Increased ionized serum Ca++ results in decreased PTH production/secretion
     Increased 1,25-dihydroxyvitamin D feeds back to inhibit PTH production/secretion
     Increased phosphate in blood directly stimulates PTH production and indirectly results in increased PTH because it binds ionized calcium (lowering ionized Ca++ levels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the production of active vitamin D. How is it inactivated?

A
  1. Production requires conversions in skin, liver and kidneys.
  2. 7-dehydrocholesterol converted to previtamin D3 in skin by ultraviolet light and then isomerized to vitamin D3.
  3. Vitamin D3 carried in blood via vitamin D-binding protein (VDBP).
  4. Liver is site of 25 hydroxylation.
  5. Dietary substrates [vitamin D2(plant sources) and vitamin D3 (animal sources)] delivered to liver
    in portal circulation for 25-hydroxylation as well.
  6. VDBP carries 25-(OH)D to kidneys where some of the 25-(OH)D is converted by 1-hydroxylation by 1-alpha-hydroxylase (Cyp1α) to the active hormone 1,25-(OH)2 D.
  7. Kidney and other tissues inactivate the majority of circulating 25-(OH)D by 24-hydroxylation (inactive form).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of the vitamin D receptor? What overall effects does vitamin D have? What are 3 ways in which it accomplishes each one?

A
  1. 1,25-(OH)2 D actions:

 Binds vitamin D receptor which then complexes with retinoid-X receptor and accessory coactivators. The VDR complex exerts transcriptional regulation of numerous genes after binding to the vitamin D response element.

 1,25-(OH)2 D raises serum Ca++ levels

a. increases intestinal Ca++ absorption
b. increases bone resorption
c. can increase renal Ca++ absorption in vitamin D –deficient states

 1,25-(OH)2 D raises serum PO4 levels

a. increases intestinal absorption
b. increases renal absorption
c. inhibits PTH production/secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the pharmacological effects of calcitonin and what is it used to treat? Where is it produced? What stimulates its secretion? What is its action?

A
  1. Physiologic role in humans unclear, but effective as a therapeutic in treatment of osteoporosis, hypercalcemia or Paget’s Disease (high bone turnover, bone pain, bone deformities). At high pharmacologic doses (parenteral or intranasal salmon calcitonin) may increase renal Ca++ excretion.
  2. Produced in C cells of the thyroid. (32 a.a.)
  3. Secretion stimulated by hypercalcemia and gastrin (?prevention of post-prandial hypercalcemia).
  4. Inhibits osteoclasts and decreases bone resorption (lowering serum Ca++).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the effect of estradiol on calcium/bone? What is the mechanism?

A

Estradiol

  1. Prevents bone resorption, increases renal Ca++ reabsorption, and augments intestinal Ca++ absorption.
  2. Postmenaopausal bone loss is a consequence of ovarian senescence.
  3. Mechanism

 Possibly via sensitizing the mechanoreceptors in bone so that in the absence of estrogen, high levels of mechanical strain are required to stimulate new bone formation.

 Possible direct effects on osteoblasts to increase survival

 Decrease pre-osteoclast differentiation and osteoclast activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What effects does testosterone have on calcium/bone? Mechanism?

A

Testosterone/Dihydrotestosterone

  1. Androgen deficiency, like estrogen deficiency, leads to rapid bone loss, which exogenous T

can reverse.

  1. Mechanism probably due to peripheral conversion of T to E (aromatase).
  2. T does increase width of bones, providing mechanical advantage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What effects do glucocorticoids have on calcium/bone? Mechanism?

A
  1. Effects of endogenous glucocorticoids not significant because of compensatory mechanisms.
  2. Longterm glucocorticoid therapy (e.g. prednisone) causes bone loss by increasing bone

resorption, decreasing bone formation (mechanism may be by causing apoptosis of

osteoblasts and osteocytes).

17
Q

What effects does GH have on calcium/bone? Mechanism?

A
  1. Increases bone remodeling, favors formation, leading to increased bone mass.
  2. Mechanism may be direct effect on osteblasts or indirect via stimulation of IGF-1

production in liver.

  1. GH deficiency results in low bone mass that responds to GH therapy.
  2. GH excess (e.g. acromegaly) actually have decreased (not increased as expected) bone mass probably due to these patients commonly being hypogonadal.
18
Q

What effects does TH have on calcium/bone? Mechanism?

A

Thyroid Hormone

  1. T3 increases bone resorption and bone loss.
  2. Increases serum ionized Ca++ levels (results in lowered PTH, vitamin D)
19
Q

What effects do local factors have on calcium/bone? Mechanism?

A
  1. After menopause up-regualtion of cytokines (IL-1, IL-6, TNF-α) promote osteoclast differentiation and increased bone resorption.
  2. RANK expression increases and OPG production decreases further driving osteoclast formation.
20
Q

What effects does PTHrP have on calcium/bone? Mechanism?

A
  1. In malignant states PTHrP is overexpressed. (homologous structure in N-terminus to PTH)
  2. Exerts actions via the same receptors and similarly increases bone resorption (causes Hypercalcemia of Malignancy).
21
Q

What effects does CaSR have on calcium/bone? Mechanism?

A
  1. Inactivating mutations of CaSR result in hypercalcemia (less inhibition of PTH release).
  2. Activating mutations result in hypocalcemia.
  3. In parathyroid gland increases in serum ionized Ca++ activate the CaSR, leading to lower PTH production/secretion (decreases result in the opposite).
  4. CaSR present on C cells of thyroid, where increased serum ionized Ca++ stimulates calcitonin release (decreases result in the opposite).
  5. Activation of CaSR in kidney (ascending limb of Henle) results in decreased Ca++ reabsorption.
  6. In bone CaSR mediates the inhibitory effect of local Ca++ levels on osteoclast function.
22
Q

Describe what happens and how it happens when Calcium levels increase. What is the major factor?

A
  1. Increased calcium intake leads to small increments in serum ionized Ca++.
  2. Compensatory mechanisms activated:

 PTH suppressed

 1-25-(OH)2 D levels fall

 Calcitonin released

 Bone resorption decreases

 Renal Ca++ excretion increases (decreased PTH, CaSR activation augments Ca++

excretion) *Kidney plays a major role in the compensation

 Intestinal Ca++ absorption decreased

23
Q

Describe what happens in hypocalcemia. What are the mechanisms at plahy? What is the major factor?

A
  1. In cases of inadequate dietary calcium intake.
  2. Increased fractional absorption of Ca++ in intestine.
  3. Hypocalcemia sensed by CaSR and PTH increases.
  4. 1-25-(OH)2 D levels rise
  5. Serum calcitonin suppressed.
  6. Resulting in increased intestinal Ca++ absorption, decreased renal Ca++ excretion, increased

bone resorption.

  1. Here all three tissues need to play a role in the compensation (not just kidney).
24
Q

What happens with calcium in immobilization? Mechanisms? Same questions for exercise.

A

Increased bone resorption and decreased formation leads to incr. serum calcium leading to decr. PTH leading to less vit. D leading to decr. intestinal absorption.

Decreased bone resorption and increased bone formation leads to decreased serum calcium which leads to increased PTH which leads to increased Vit D which leads to increased intestinal absorption.

25
What are the effects of hypercalcemia on the nervous system? MS? GI? Kidney? What are two major causes of hypercalcemia?
Symptoms of Hypercalcemia Nervous system: fatigue, lethargy, depression, psychosis, reduced concentration Muscle/skeletal weakness: pain in bone and joints, fractures GI system: polydipsia, anorexia, nausea, emesis, weight loss, constipation, abdominal pain Kidney polyuria, nocturia, kidney stones (hematuria, dysuria) Primary hyperparathyroidism, Hypercalcemia of malignancy
26
What is the pathophys of PHPT? How does it present? What are some exam findings? Treatment?
Primary Hyperparathyroidism (PHPT) 1. Excess PTH (adenoma source or multiple glandular neoplasia) 2. Present often with kidney stones, bone pain, fractures, abdominal pain or psychiatric symptoms 3. Low bone mineral density upon examination 4. Treatment: surgery to remove tumor source
27
Describe the mechanisms of PTHrP. What are various levels of the different hormones/ions involved in calcium homeostasis? What is the treatment? What is the local factor mechanism? Describe how vit d mediated hypercalcemia can occur.
1. PTHrP Mechanism (Humoral Hypercalcemia of Malignancy) a. PTHrP binds to same receptor as PTH b. Increased serum Ca++ , Low to low-normal serum phosphate c. Increased urinary Ca++, phosphate and cAMP d. Differs from PHPT in that 1-25-(OH)2 D levels not increased e. Like PHPT increased bone resorption, but less bone reformation so serum and urinary Ca++ levels rise more and often quickly f. Treatment: Bisphosphonates to inhibit osteoclast activity (target osteoclasts to apoptosis); Prednisone to block intestinal Ca++ absorption and increase renal Ca++ excretion 2. Local Factor Mechanism a. Increased paracrine factors (e.g. IL-1, IL-6, TNF, PGE2, RANKL) drive bone resorption b. Tumor source 3. Vitamin D-mediated hypercalcemia a. In rare cases, lymphomas express 1-alpha-hydroxylase and make 1-25-(OH)2 D b. Intestinal calcium absorption increases, but in the absence of renal disease the kidneys can compensate
28
What are the symptoms of hypocalcemia in smooth muscle, skeletal muscle, neural, and cardiac? What are 3 major causes of hypocalcemia?
Neuromuscular excitability paresthesias, numbness or tingling muscle cramping in hands and feet (carpopedal spasms) Smooth muscle abdominal pain, bronchospasm, laryngospasm (wheezing and shortness of breath) Neural psychosis, seizures Cardiac arrhythmias, palpitations Lack of PTH, lack of Vit. D, binding/redistribution problems.
29
What are 3 mechanisms of decreased PTH? How do they present? How are they treated?
1. Post surgical hypoparathyroidism (surgical resection of thyroid) 2. Autoimmune destruction of gland 3. PTH resistance 4. All three display hypocalcemia with hyperphosphatemia 5. Treat with calcium supplementation and Calcitriol.
30
What are two main etiologies for decreased Vit. D? What are some subetiologies for each? How is each main etiology treated?
Lack of Vitamin D 1. Inadequate nutrients/sunlight a. 400 IU recommended daily allowance (vitamin D relatively low in most foods) b. Vitamin D production in skin important and can be compromised by low UV light exposure, heavy skin pigmentation, ageing. c. Treat with calcium supplements, Calcitriol (vitamin D) and sunlight 2. Impaired production a. Liver disease (inadequate 25-hydroxylation) b. Renal failure (inadequate 1-hydroxylation) c. Hypoparathyroidism d. Treat with calcium supplements and Calcitriol.
31
Describe 3 ways in which binding/redistribution problems can lead to hypocalcemia. How are they treated?
Binding/Redistribution Problems 1. Elevated serum phosphate binds and precipitates calcium ( as in renal failure or massive tissue damage) 2. Citrate binds calcium and lowers ionized levels (even though total normal) 3. Alkalosis lowers also ionized but not total calcium levels by increasing binding to albumin 4. Treat with calcium supplementation and Calcitriol.
32
Study Table
Study Table.
33
What cells are present in the parathyroid? What is the function of PTH? How is PTH release regulated?
A. Chief cells regulate serum free (ionized) calcium via parathyroid hormone (PTH ) secretion, which 1 . Increases bone osteoclast activity (by increasing bone osteoblast activity), releasing calcium and phosphate 2. Increases small bowel absorption of calcium and phosphate (indirectly by activating vitamin D) 3 . Increases renal calcium reabsorptio n (distal tubule) and decreases phosphate reabsorptio n (proximal tubule) B. Increased serum ionized calcium levels provide negative feedback to decrease PTH secretion.
34
What is the most common cause of PHPT? Other causes? What is the most common result of this cause? What are some other presentations? What lab findings are there? Treatment?
A. Excess PTH due to a disorder of the parathyroid gland itself B. Most c o m m o n cause is parathyroid adenoma (>80% of cases); sporadic parathyroid hyperplasia and parathyroid carcinoma are less commo n causes, C Parathyroid adenoma is a benign neoplasm, usually involving one gland, 1 . Mos t ofte n results in asymptomati c hypercalcemia; however, may present with consequences of increased PTH and hypercalcemia such as i. Nephrolithiasis (calcium oxalate stones) ii. Nephroc a lci no sis—metastatic calcification of renal tubules (Pig. 15.9), potentially leading to renal insufficiency and polyuria iii. CNS disturbances (e.g., depression and seizures) iv. Constipation.peptic ulcerdisease,and acute pancreatitis v. Osteitis fibrosa cystica—resorption of bone leading to fibrosis and cystic spaces (Pig. 15.10) 2. Laboratory findings include incr. serum PTH, incr. serum calcium, decr. serum phosphate, incr. urinary cAMP, and incr. serum alkaline phosphatase. 3 . Treatment involves surgical removal of the affected gland,
35
What is secondary HPT? What is the most common cause? What is the pathogenesis of this most common cause? What are the lab findings?
A. Excess production of PTH due to a disease process extrinsic to the parathyroid gland B. Most c o m m o n cause is chronic renal failure. 1. Renal insufficiency leads to decreased phosphateexcretion. 2. T serum phosphate binds free calcium, 3 . Decr. free calcium stimulates all four parathyroid glands. 4. Incr. PTH leads to bone resorption (contributing to renal osteodystrophy). 5. Lab findings include incr. PTH , decr. serum calcium, incr. serum phosphate, and incr. alkaline phosphatase.
36
What is hypoparathyroidism? What are some causes? How does it present? Lab findings?
IV. H Y P O P A R A T H Y R O I D I S M A. L o w P T H B . Causes include autoimmune damage to the parathyroids , surgical excision, and DiGeorge syndrome C. Presents with symptoms related to low serum calcium 1 . Numbness and tingling (particularly perioral) 2. Muscle spasms (tetany)—may be elicited with filling of a blood pressure cuff (Trousseau sign) or tapping on the facial nerve (Chvostek sign) D. Labs reveal decr. P T H levels and decr. serum calcium.
37
What is pseudohypoparathyroidism? What causes it? What labs will there be? What is the autosomal dominant form associated with?
E. Pseudohypoparathyroidis m is due to end-organ resistance to PTH , 1. Labs reveal hypocalcemia with incr. PTH levels. 2. Autosomal dominant form is associated with short stature and short 4th and 5th digits.